Cancer Drug Delivery and Nanotechnology II

Track Chair(s)

• 

  Jan Lammerding, PhD (he/him/his)

  Professor
  Cornell University
  Ithaca, New York, United States
• JW

  Jessica Winter

  Professor
  The Ohio State University, United States

Moderator(s)

• 

  Richard Heller, PhD

  Professor
  University of South Florida
  Tampa, Florida, United States
• JM

  Jyothi Menon

  University of Rhode Island
  Kingston, Rhode Island, United States

Presentations:

• 12:30 PM – 12:45 PM PDT

  Prostate Specific Membrane Antigen Targeted Photodynamic Therapy Agent for the Treatment of Breast Cancer
  

  Presenting Author: Aditi A. Shirke, BSE (she/her/hers) – Case Western Reserve University

  Co-Author: Xinning Wang (she/her/hers) – Case Western Reserve University

  Primary Investigator: James Basilion (he/him/his) – Case Western Reserve University
• 12:45 PM – 1:00 PM PDT

  Nuclear morphology predicts cell survival to cisplatin chemotherapy
  

  Presenting Author: Chi-Ju Kim, PhD (he/him/his) – Johns Hopkins University School of Medicine

  Co-Author: Anna Gonye – Johns Hopkins University School of Medicine

  Co-Author: Kevin Truskowski – Johns Hopkins University School of Medicine

  Co-Author: Cheng-Fan Lee – Johns Hopkins University School of Medicine

  Co-Author: Yoon-Kyoung Cho – UNIST & IBS

  Co-Author: Robert Austin – Princeton University

  Co-Author: Kenneth Pienta – Johns Hopkins University School of Medicine

  Last Author: Sarah Amend – Johns Hopkins University School of Medicine
• 1:00 PM – 1:15 PM PDT

  Characterizing VEGFR-2 Phosphorylation Patterns Due to Strain and Anti-Angiogenic Therapies
  

  Presenting Author: Bronte Miller, MS (she/her/hers) – The University of Alabama at Birmingham

  Co-Author: Michael D. Heim (he/him/his) – The University of Alabama at Birmingham

  Primary Investigator: MK Sewell-Loftin (she/her/hers) – The University of Alabama at Birmingham
• 1:15 PM – 1:30 PM PDT

  Formulation Development of a Conjugatable Junction Opener Protein for DSG2 Positive Tumor Disruption
  

  Presenting Author: Adrian Simpson – HDT Bio

  Primary Investigator: Amit P. Khandhar, PhD (he/him/his) – HDT Bio

  Co-Author: Jiho Kim – PAI Life Sciences

  Co-Author: Darrick Carter – PAI Life Sciences

  Co-Author: Jim Reed – HDT Bio
• 1:30 PM – 1:45 PM PDT

  A novel non-apoptotic compound prevents breast cancer intravasation by protecting endothelial cells in a microfluidic model
  

  Presenting Author: Indira Sigdel (she/her/hers) – University of Toledo

  Co-Author: Awurama Ofori-Kwafo (she/her/hers) – University of Toledo

  Co-Author: Khalid Khalaf (he/him/his) – University of Toledo

  Co-Author: Andrea Nestor-Kalinoski (she/her/hers) – University of Toledo

  Co-Author: Amit K. Tiwari (he/him/his) – University of Toledo

  Last Author: Yuan Tang (he/him/his) – University of Toledo
• 1:45 PM – 2:00 PM PDT

  Acquired temozolomide resistance instructs patterns of glioblastoma cell motility, pro-angiogenic cytokine production, and response to repeated drug exposure in gelatin hydrogels
  

  Presenting Author: Victoria Kriuchkovskaia – University of Illinois Urbana-Champaign

  Co-Author: Rebecca B. Riggins – Georgetown University

  Primary Investigator: Brendan A.C. Harley – Department of Chemical and Biomolecular Engineering, University of Illinois Urbana Champaign